الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 198 |  |  |
| | | from | 198 | | |
Abstract
Mesenteric venous resection with reconstruction has been an accepted practice for pancreatic cancer with involvement of the SMV or PV when studies demonstrated equivalent survival of patients undergoing margin-negative venous resection compared to patients undergoing standard pancreaticoduodenectomy, as well as superiority of resection compared to nonsurgical treatment.
More recent studies demonstrated that vein resection was not associated with worse overall survival at 1, 3, or 5 years. Other recent studies have also demonstrated patients with PV/SMV resection had equivalent survival outcome.
Some studies have reported increased morbidity associated with venous reconstruction, providing caution to those considering this technique. Therefore venous resection, when R0 resection can be reasonably expected, has been accepted as the standard of care for indicated patients.